Picture of Nanosynth logo

NNN Nanosynth Share Price

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Momentum

Relative Strength (%)
1m-10.59%
3m-75.22%
6m-83.01%
1yr-84.74%
Volume Change (%)
10d/3mn/a
Price vs... (%)
52w Highn/a
50d MAn/a
200d MAn/a

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-109.37%
Return on Equity-71.43%
Operating Margin-4501.58%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202231st Dec 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Nanosynth EPS forecast chart

Profile Summary

nanosynth group plc is a United Kingdom-based nano-technology business that originated in Nottingham from a partnership with Nottingham Trent University. The Company specializes in the synthesis and application of nanoparticles to create new and improve existing products. The Company is focused on developing commercial applications to enhance existing products and to develop new products, leveraging its platform nanotechnology and material science across a range of industry sectors and markets. It uses patented technology to reproducibly synthesize and functionalize nanoparticles that are homogenous. Its technology developed at Nottingham Trent University, uses a spinning disk reactor to control both the size and shape of the nanoparticles, making its process efficient and scalable for a variety of applications. The Company has two operating subsidiaries, Nanovate Ltd and Virosynth Ltd, each of which is focused on specific industry applications of the core technology.

Directors

Last Annual
December 31st, 2021
Last Interim
June 30th, 2022
Incorporated
July 1st, 2014
Public Since
November 17th, 2014
No. of Employees
10
Sector
Biotechnology & Medical Research
Industry
Healthcare
Exchange
gb flag iconLondon Stock Exchange
Shares in Issue
2,873,744,208

NNN Share Price Performance

Similar to NNN

Picture of 4Basebio logo

4Basebio

gb flag iconLondon Stock Exchange

Picture of Allergy Therapeutics logo

Allergy Therapeutics

gb flag iconLondon Stock Exchange

Picture of Arecor Therapeutics logo

Arecor Therapeutics

gb flag iconLondon Stock Exchange

Picture of Avacta logo

Avacta

gb flag iconLondon Stock Exchange

Picture of Batm Advanced Communications logo

Batm Advanced Communications

gb flag iconLondon Stock Exchange

FAQ